ART Inhibitors

Santa Cruz Biotechnology now offers a broad range of ART Inhibitors for use in various applications. ART inhibitors target ADP-ribosyltransferases (ARTs), a group of enzymes that play a pivotal role in post-translational modifications by transferring ADP-ribose from NAD+ to target proteins. This process, known as ADP-ribosylation, is crucial for regulating various cellular processes, including DNA repair, gene expression, and signal transduction. Inhibitors of ARTs are essential tools in scientific research, allowing researchers to delve into the complex mechanisms by which ADP-ribosylation affects cellular function. By inhibiting ARTs, scientists can explore how these enzymes regulate the cellular response to stress, maintain genomic stability, and influence cell signaling pathways. ART inhibitors are particularly valuable in studies focused on understanding the role of ADP-ribosylation in chromatin remodeling and the regulation of transcriptional networks. These inhibitors are also used to investigate the involvement of ARTs in the modification of proteins associated with the cell cycle, apoptosis, and immune responses. The use of ART inhibitors extends to research on cellular metabolism, where ADP-ribosylation is known to influence energy production and consumption. Additionally, these inhibitors are employed in exploring the crosstalk between ADP-ribosylation and other post-translational modifications, providing insights into the intricate regulatory networks that control cellular physiology. The availability of a broad range of ART inhibitors enables researchers to design experiments tailored to specific aspects of ADP-ribosylation, advancing our understanding of this critical modification and its implications for cell biology. View detailed information on our available ART Inhibitors by clicking on the product name.